Bing Xu

1.7k total citations · 1 hit paper
43 papers, 1.4k citations indexed

About

Bing Xu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Bing Xu has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Bing Xu's work include Peptidase Inhibition and Analysis (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and RNA modifications and cancer (6 papers). Bing Xu is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and RNA modifications and cancer (6 papers). Bing Xu collaborates with scholars based in China, United States and Japan. Bing Xu's co-authors include Mingzuo Jiang, Yongzhan Nie, Jie Liang, Daiming Fan, Kaichun Wu, Yi Chu, Zhaojian Liu, Changshun Shao, Yaoqin Gong and Xiaotian Chang and has published in prestigious journals such as PLoS ONE, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Bing Xu

40 papers receiving 1.4k citations

Hit Papers

Gasdermin D plays a key role as a pyroptosis executor of ... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
    2017 336 citations Bing Xu, Mingzuo Jiang et al. Journal of Hepatology profile →

Peers

Bing Xu
Xiao Yao China
Xiaojie Ma China
Fang Fang China
Shan Deng China
Jianrui Song China
Tae Hyeon Koo South Korea
Yueh-Min Lin Taiwan
Leilei Du China
Xiao Yao China
Bing Xu
Citations per year, relative to Bing Xu Bing Xu (= 1×) peers Xiao Yao

Countries citing papers authored by Bing Xu

Since Specialization
Citations

This map shows the geographic impact of Bing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xu more than expected).

Fields of papers citing papers by Bing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xu. The network helps show where Bing Xu may publish in the future.

Co-authorship network of co-authors of Bing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Xu. A scholar is included among the top collaborators of Bing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Xu. Bing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Rui, Han Zhang, Huan Chen, et al.. (2025). α-Tocopherol Ameliorates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation by Promoting Nrf2 Nuclear Translocation. Antioxidants and Redox Signaling. 43(16-18). 833–848. 1 indexed citations
2.
3.
Zhao, Zhengwei, Ze‐Guang Han, Yu‐Hsuan Joni Shao, et al.. (2024). Effects of trypsin and pepsin detection on chronic otitis media with effusion. Heliyon. 10(21). e40112–e40112. 2 indexed citations
4.
Zhao, Tianming, Kang Jiang, Ying Kang, et al.. (2024). O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36. Metabolism. 156. 155914–155914. 20 indexed citations
5.
Lai, Qian, Qinwei Chen, Li Zhang, et al.. (2022). Anlotinib exerts potent antileukemic activities in Ph chromosome negative and positive B-cell acute lymphoblastic leukemia via perturbation of PI3K/AKT/mTOR pathway. Translational Oncology. 25. 101516–101516. 4 indexed citations
6.
Yin, Jipeng, Xin Bo, Mingru Zhang, et al.. (2021). 68Ga-Labeled GX1 Dimer: A Novel Probe for PET/Cerenkov Imaging Targeting Gastric Cancer. Frontiers in Oncology. 11. 750376–750376. 3 indexed citations
7.
Chen, Fangyu, et al.. (2021). Integrated Analysis of Cell Cycle–Related and Immunity-Related Biomarker Signatures to Improve the Prognosis Prediction of Lung Adenocarcinoma. Frontiers in Oncology. 11. 666826–666826. 19 indexed citations
8.
Xu, Bing, et al.. (2021). DEAD-Box Helicase 3 X-Linked Promotes Metastasis by Inducing Epithelial-Mesenchymal Transition via p62/Sequestosome-1. Digestive Diseases and Sciences. 66(11). 3893–3902. 4 indexed citations
9.
Li, Shufeng, et al.. (2021). Additive Effects of VDBP and 1,25(OH)2D3 on the Viability and Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts. Frontiers in Endocrinology. 11. 583229–583229. 3 indexed citations
10.
Jiang, Mingzuo, Nan Wu, Xi Chen, et al.. (2019). Pathogenesis of and major animal models used for nonalcoholic fatty liver disease. Journal of International Medical Research. 47(4). 1453–1466. 24 indexed citations
11.
Jiang, Mingzuo, Nan Wu, Bing Xu, et al.. (2019). Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis. Theranostics. 9(18). 5359–5373. 120 indexed citations
12.
Wang, Huaqing, Yong Zeng, Minghui Zhang, et al.. (2019). CD56brightCD16− natural killer cells are shifted toward an IFN-γ-promoting phenotype with reduced regulatory capacity in osteoarthritis. Human Immunology. 80(10). 871–877. 14 indexed citations
13.
Su, Song, Zhenzhen Liu, Fang Wang, et al.. (2019). Aplastic anemia associated with Crohn’s disease: a tertiary center retrospective study. Annals of Hematology. 98(9). 2053–2061. 1 indexed citations
14.
Li, Xiaowei, Mingzuo Jiang, Di Chen, et al.. (2018). miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis. Journal of Experimental & Clinical Cancer Research. 37(1). 71–71. 43 indexed citations
15.
Wu, Nan, Yuying Han, Haiming Liu, et al.. (2018). miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway. Biochemical and Biophysical Research Communications. 503(3). 1491–1497. 34 indexed citations
16.
Jiang, Mingzuo, Bing Xu, Xiaowei Li, et al.. (2018). O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit. Oncogene. 38(3). 301–316. 113 indexed citations
17.
Xu, Bing, Mingzuo Jiang, Yi Chu, et al.. (2017). Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. Journal of Hepatology. 68(4). 773–782. 336 indexed citations breakdown →
18.
Wang, Huifeng, Bing Xu, Xiaoqian Zhang, et al.. (2016). PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling. Cancer Cell International. 16(1). 61–61. 34 indexed citations
19.
Zheng, Yabing, Bing Xu, Yan Zhao, et al.. (2015). CA1 contributes to microcalcification and tumourigenesis in breast cancer. BMC Cancer. 15(1). 679–679. 28 indexed citations
20.
Liu, Qiao, Haiyan Jiang, Zhaojian Liu, et al.. (2011). Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51. PLoS ONE. 6(8). e23427–e23427. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao Yao Breakdown of academic impact, for papers by Xiaojie Ma Breakdown of academic impact, for papers by Fang Fang Breakdown of academic impact, for papers by Shan Deng Breakdown of academic impact, for papers by Jianrui Song Breakdown of academic impact, for papers by Tae Hyeon Koo Breakdown of academic impact, for papers by Yueh-Min Lin Breakdown of academic impact, for papers by Leilei Du
Rankless by CCL
2026